144 related articles for article (PubMed ID: 11673572)
1. Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS.
Durelli L; Ferrero B; Oggero A; Verdun E; Ghezzi A; Montanari E; Zaffaroni M;
Neurology; 2001 Oct; 57(8):1363-70. PubMed ID: 11673572
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?
Verdun E; Isoardo G; Oggero A; Ferrero B; Ghezzi A; Montanari E; Zaffaroni M; Durelli L;
J Interferon Cytokine Res; 2002 Feb; 22(2):245-55. PubMed ID: 11911808
[TBL] [Abstract][Full Text] [Related]
3. Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study.
Durelli L; Ferrero B; Oggero A; Verdun E; Ghezzi A; Montanari E; Zaffaroni M;
J Clin Endocrinol Metab; 2001 Aug; 86(8):3525-32. PubMed ID: 11502774
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune events during interferon beta-1b treatment for multiple sclerosis.
Durelli L; Ferrero B; Oggero A; Verdun E; Bongioanni MR; Gentile E; Isoardo GL; Ricci A; Rota E; Bergamasco B; Durazzo M; Saracco G; Biava MA; Brossa PC; Giorda L; Pagni R; Aimo G
J Neurol Sci; 1999 Jan; 162(1):74-83. PubMed ID: 10064173
[TBL] [Abstract][Full Text] [Related]
5. Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study.
Durelli L; Oggero A; Verdun E; Isoardo GL; Barbero P; Bergamasco B; Brossa PC; Ghigo E; Maccario M; Faggiano F;
J Neurol Sci; 2001 Dec; 193(1):17-22. PubMed ID: 11718745
[TBL] [Abstract][Full Text] [Related]
6. Long-term interferon beta-1b therapy for MS: is routine thyroid assessment always useful?
Monzani F; Caraccio N; Casolaro A; Lombardo F; Moscato G; Murri L; Ferrannini E; Meucci G
Neurology; 2000 Aug; 55(4):549-52. PubMed ID: 10953190
[TBL] [Abstract][Full Text] [Related]
7. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis.
Uzawa A; Mori M; Hayakawa S; Masuda S; Kuwabara S
Eur J Neurol; 2010 May; 17(5):672-6. PubMed ID: 20039942
[TBL] [Abstract][Full Text] [Related]
8. Interferon beta-1b treatment does not induce autoantibodies.
Polman CH; Kappos L; Dahlke F; Graf R; Beckmann K; Bogumil T; Pozzilli C; Thompson AJ;
Neurology; 2005 Mar; 64(6):996-1000. PubMed ID: 15781815
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis.
Monzani F; Caraccio N; Meucci G; Lombardo F; Moscato G; Casolaro A; Ferdeghini M; Murri L; Ferrannini E
Eur J Endocrinol; 1999 Oct; 141(4):325-31. PubMed ID: 10526243
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a or 1b therapy: predictive factors of thyroid disease development and duration.
Caraccio N; Dardano A; Manfredonia F; Manca L; Pasquali L; Iudice A; Murri L; Ferrannini E; Monzani F
J Clin Endocrinol Metab; 2005 Jul; 90(7):4133-7. PubMed ID: 15811929
[TBL] [Abstract][Full Text] [Related]
11. Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement.
Tamura S; Warabi Y; Matsubara S
J Clin Pharm Ther; 2012 Dec; 37(6):724-5. PubMed ID: 22642738
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis.
Rotondi M; Oliviero A; Profice P; Mone CM; Biondi B; Del Buono A; Mazziotti G; Sinisi AM; Bellastella A; Carella C
J Endocrinol Invest; 1998 Dec; 21(11):748-52. PubMed ID: 9972674
[TBL] [Abstract][Full Text] [Related]
13. Does high-dose interferon beta-1b improve clinical response in more severely disabled multiple sclerosis patients?
Durelli L; Oggero A; Verdun E; Isoardo G; Ricci A; Barbero P; Bergamasco B
J Neurol Sci; 2000 Sep; 178(1):37-41. PubMed ID: 11018247
[TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis.
Daniels GH; Vladic A; Brinar V; Zavalishin I; Valente W; Oyuela P; Palmer J; Margolin DH; Hollenstein J
J Clin Endocrinol Metab; 2014 Jan; 99(1):80-9. PubMed ID: 24170099
[TBL] [Abstract][Full Text] [Related]
15. Interferon beta treatment for multiple sclerosis: persisting questions.
Goodkin DE
Mult Scler; 1996 Jul; 1(6):321-4. PubMed ID: 9345408
[TBL] [Abstract][Full Text] [Related]
16. Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Frisullo G; Calabrese M; Tortorella C; Paolicelli D; Ragonese P; Annovazzi P; Radaelli M; Malucchi S; Gallo A; Tomassini V; Nociti V; D'Onghia M; Lo Re V; Rodegher M; Solaro C; Gasperini C
Mult Scler; 2014 Aug; 20(9):1265-8. PubMed ID: 24515732
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease.
Rotondi M; Mazziotti G; Biondi B; Manganella G; Del Buono AD; Montella P; di Cristofaro M; Di Iorio G; Amato G; Carella C
J Endocrinol Invest; 2000 May; 23(5):321-4. PubMed ID: 10882151
[TBL] [Abstract][Full Text] [Related]
18. Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.
Baum K; O'Leary C; Coret Ferrer F; Klímová E; Procházková L; Bugge J;
Mult Scler; 2007 Nov; 13(9):1153-60. PubMed ID: 17967843
[TBL] [Abstract][Full Text] [Related]
19. Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Schippling S; O'Connor P; Knappertz V; Pohl C; Bogumil T; Suarez G; Cook S; Filippi M; Hartung HP; Comi G; Jeffery DR; Kappos L; Goodin DS; Arnason B
J Neurol; 2016 Jul; 263(7):1418-26. PubMed ID: 27177997
[TBL] [Abstract][Full Text] [Related]
20. An open-labelled assessment of adverse effects associated with interferon 1-beta in the treatment of multiple sclerosis.
Logan-Clubb L; Stacy M
J Neurosci Nurs; 1995 Dec; 27(6):344-7. PubMed ID: 8770778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
